Skip to content

Released Mar 1, 2023, after the close

10-K filed Mar 1, 2023, 60 days after period end · 0001628280-23-005832

Q4 2022 · 10-K

derived · Computed from the longer spans the company filed.

Revenue$62.04Mderived+41.1% vs Q4 2021+8.9% vs Q3 2022
Net Income-$61.77MderivedN/M vs Q4 2021N/M vs Q3 2022
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$97,294,000N/M
Operating Cash Flowderived-$109,292,000N/M
Free Cash Flowderived-$113,705,000N/M
Margins · derived
Operating margin-156.8%+341.8 pt vs Q4 2021
Net margin-99.6%+382.2 pt vs Q4 2021

What the release said

The release

Same quarter

MetricQ4 2022derived from reported figuresQ4 2021Q4 2020Q4 2019derived from reported figures
Revenue$62.04M$43.96M$15.09M$4.65M
Net Income-$61.77M-$211.83M-$76.55M-$46.43M
EPS Diluted—-$2.22-$0.88—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Zai Lab Ltd · CIK 1704292 · Engraved from SEC EDGAR